首页> 外文OA文献 >A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

【2h】

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

机译：枸Fer酸亚铁治疗12周，双盲，安慰剂对照试验，用于CKD 3-5期患者的铁缺乏性贫血和血清磷酸盐的减少

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Block Geoffrey A.; Fishbane Steven; Rodriguez Mariano; Smits Gerard; Shemesh Shay; Pergola Pablo E.; Wolf Myles; Chertow Glenn M.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5 [J] . Block Geoffrey A., Fishbane Steven, Rodriguez Mariano, American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2015,第5期

机译：枸Fer酸亚铁治疗12周，双盲，安慰剂对照试验，用于CKD 3-5期患者的铁缺乏性贫血和血清磷酸盐的减少
2. AURYXIA (FERRIC CITRATE) EFFECTIVELY REDUCES SERUM PHOSPHATE AND FIBROBLAST GROWTH FACTOR 23 (FGF23) LEVELS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD) [J] . Block Geoffrey A., Chertow Glenn M., Fishbane Steven, American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2015,第4期

机译：AURYXIA（柠檬酸铁）有效地降低了3-5岁慢性肾脏病（CKD）患者的血清磷酸盐和成纤维细胞生长因子23（FGF23）水平
3. AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD) [J] . Fishbane Steven, Block Geoffrey A., Loram Lisa C., American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2015,第4期

机译：AURYXIA（柠檬酸铁），一种口服铁基磷酸盐结合剂，可显着改善第3、4和5期慢性肾脏病（CKD）患者的血清铁含量
4. A 12-Week Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial for Evaluation of the Efficacy and Safety of DKB114 on Reduction of Uric Acid in Serum [O] . Yu Hwa Park, Do Hoon Kim, Jung Suk Lee, 2020

机译：为期12周多中心随机双盲安慰剂对照临床对照临床试验用于评估DKB114对血清中尿酸还原的疗效和安全性
5. The effect of Vitamin D administration on treatment of anemia in end-stage renal disease patients with Vitamin D deficiency on hemodialysis: A placebo-controlled, double-blind clinical trial [O] . Afsoon Emami Naini, Zahra Parin Hedaiati, Danial Gholami, 2015

机译：维生素D给药对血液透析维生素D缺乏的终末期肾病患者贫血的影响：安慰剂对照，双盲临床试验

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

著录项

引文网络

相似文献

相关主题

期刊订阅